| Literature DB >> 31063482 |
Laura Adelaide Dalla Vecchia1, Franca Barbic2, Beatrice De Maria1, Domenico Cozzolino3, Roberto Gatti2, Franca Dipaola2, Enrico Brunetta2, Antonio Roberto Zamuner4, Alberto Porta5,6, Raffaello Furlan2.
Abstract
Regular exercise is recommended to improve the cardiovascular risk profile. However, there is growing evidence that extreme volumes and intensity of long-term exertion may increase the risk of acute cardiac events. The aim of this study is to investigate the after-effects of regular, strenuous physical training on the cardiovascular neural regulation in a group of amateur triathletes compared to age-matched sedentary controls. We enrolled 11 non-elite triathletes (4 women, age 24±4 years), who had refrained from exercise for 72 hours, and 11 age-matched healthy non-athletes (3 women, age 25±2 years). Comprehensive echocardiographic and cardiopulmonary exercise tests were performed at baseline. Electrocardiogram, non-invasive blood pressure, respiratory activity, and muscle sympathetic nerve activity (MSNA) were continuously recorded in a supine position (REST) and during an incremental 15° step-wise head-up tilt test up to 75° (TILT). Blood samples were collected for determination of stress mediators. Autoregressive spectral analysis provided the indices of the cardiac sympathetic (LFRR) and vagal (HFRR) activity, the vascular sympathetic control (LFSAP), and the cardiac sympatho-vagal modulation (LF/HF). Compared to controls, triathletes were characterized by greater LFRR, LF/HF ratio, LFSAP, MSNA, and lower HFRR at REST and during TILT, i.e. greater overall cardiovascular sympathetic modulation together with lower cardiac vagal activity. Cortisol and adrenocorticotropic hormone concentrations were also higher in triathletes. In conclusion, triathletes were characterized by signs of sustained cardiovascular sympathetic overactivity. This might represent a risk factor for future cardiovascular events, given the known association between chronic excessive sympathetic activity and increased cardiovascular risk.Entities:
Mesh:
Year: 2019 PMID: 31063482 PMCID: PMC6504093 DOI: 10.1371/journal.pone.0216567
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Demographic features of controls and triathletes.
| Controls | Triathletes | p | |
|---|---|---|---|
| Gender (m/f) | 8/3 | 7/4 | 0.99 |
| Age (years) | 25±2 | 24±4 | 0.333 |
| BMI (kg/m2) | 17.6±8.6 | 19.6±6.5 | 0.6 |
| BSA (m2) | 1.84±0.2 | 1.86±0.19 | 0.8 |
BMI indicates body mass index, BSA body surface area. Values are expressed as mean±standard deviation.
Echocardiographic and CPET features of controls and triathletes.
| Controls | Triathletes | p | |
|---|---|---|---|
| LAD (mm) | 31.4±2.1 | 35±1.4 | |
| IVS (mm) | 8±1.2 | 11±1.2 | |
| PW (mm) | 8.2±0.9 | 10±0.5 | |
| LVEDV (ml/m2) | 60±6 | 68.4±7.5 | |
| LVESV (ml/m2) | 33.8±4.1 | 36.7±2.8 | |
| LVEF (%) | 58±0.5 | 57±2.4 | 0.3 |
| RVEDA (cm2) | 17.2±2.6 | 17.5±2.2 | 0.7 |
| RVESA (cm2) | 8.7±1.4 | 8.5±1.8 | 0.7 |
| Peak VO2 (ml/kg/min) | 39.5±5.0 | 53.2±3.8 |
LAD indicates left atrial diameter, IVS diastolic interventricular septum thickness, PW diastolic posterior wall thickness, LVEDV left ventricular end-diastolic volume, LVESV left ventricular end-systolic volume, LVEF left ventricular ejection fraction., RVEDA right ventricular end-diastolic area, RVESA right ventricular end-systolic area. CPET cardiopulmonary exercise test, VO2 maximal oxygen consumption at peak of the CPET. Values are expressed as mean standard deviation. p<0.05 was considered as significant.
Indices of cardiovascular autonomic control in controls and triathletes at rest and during 75° head-up tilt.
| REST | TILT | |||
|---|---|---|---|---|
| Controls | Triathletes | Controls | Triathletes | |
| RR, ms | 935±108 | 1065±68 | 652±68 | 801±157 |
| σ2RR, ms2 | 2593±1368 | 6371±4790 | 1580±1336 | 4665±5470 |
| LFRR, ms2 | 890±557 | 2575±2098 | 929±754 | 2059±2023 |
| LFRRnu | 45±11 | 58±7 | 76±5 | 87±7 |
| HFRR, ms2 | 873±674 | 1709±1258 | 259±278 | 401±575 |
| HFRRnu | 44±8 | 33±8 | 19±6 | 11±6 |
| LF/HF | 1.08±0.38 | 1.84±0.49 | 4±1 | 10±5 |
| SAP, mmHg | 120±11 | 115±11 | 119±9 | 119±16 |
| σ2SAP, mmHg2 | 6±5 | 12±7 | 19±14 | 18±8 |
| LFSAP, mmHg2 | 2±1 | 4±3 | 4±3 | 10±5 |
REST indicates resting condition, TILT 75° head-up tilt, RR R-R interval, σ2RR variance of RR interval, LF low frequency component, HF high frequency component, nu normalized unit, LF/HF low frequency/high frequency ratio, SAP systolic arterial pressure, σ2SAP variance of SAP. Values are expressed as mean ± standard deviation.
* p<0.5 REST vs TILT
# p<0.05 controls vs triathletes.
Fig 1Original traces of the recorded variables in a control subject and in an athlete while supine (REST) and during head-up tilt test at 75° (TILT).
Recording of 30 seconds of continuous electrocardiogram (ECG), non-invasive blood pressure (BP), and muscle sympathetic nerve activity (MSNA): despite a slower heart rate, MSNA depicts a greater sympathetic activity in the triathlete.
Fig 2Muscle sympathetic nerve activity while supine (REST) and during head-up tilt test at 75° (TILT).
Triathletes (white bars) are characterized by greater sympathetic discharge activity compared to controls (black bars), also regardless of heart rate. * p<0.05 REST vs TILT; # p< 0.05 controls vs triathletes.
Stress mediators in controls and triathletes while supine and during head-up tilt test at 75°.
| REST | TILT | |||
|---|---|---|---|---|
| Controls | Triathletes | Controls | Triathletes | |
| E, pg/ml | 40±23 | 45±27 | 103±67 | 95±46 |
| NE, pg/ml | 293±129 | 353±159 | 625±107 | 617±175 |
| Renin, pg/ml | 9±7 | 10±7 | 8±5 | 9±4 |
| Aldosterone, pg/ml | 105±53 | 144±101 | 72±43 | 127±71 |
| ACTH, pg/ml | 15±4 | 73±41 | 18±7 | 56±43 |
| Cortisol, ng/ml | 91±42 | 156±92 | 86±32 | 180±86 |
| ANP, pg/ml | 69±36 | 72±44 | 94±30 | 95±62 |
REST indicates resting condition, TILT 75° head-up tilt, E plasma epinephrine, NE plasma norepinephrine, ACTH plasma adrenocorticotropic hormone, ANP plasma atrial natriuretic peptide.
* p<0.5 REST vs TILT
# p<0.05 controls vs triathletes.